Please assess the completion status of the following clinical trial:

Trial Title: Study Using WST11 in Patients With Non-Resectable or Inoperable Cholangiocarcinoma

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Patient having signed the consent form to take part in the study~* Patient aged over 18 years, with no upper age limit~* Patient with histologically proven cholangiocarcinoma~* Patient with cholangiocarcinoma, inoperable or non resectable owing to extension, age or concomitant diseases~* Bilirubin level decrease of more than 50% after stent insertion compared to base level~* Patient with a WHO Performance Scale ≤ 2~* Patient in whom efficient drainage is performed by means of a plastic biliary stent endoscopically or radiologically~* Patient capable of completing the quality of life questionnaires~* Women of child-bearing potential must have a negative pregnancy test, and must thereafter prove to be using acceptable contraception (oral contraceptive pill, hormone patches, or IUD)~Exclusion Criteria:~* Absence of consent to take part in the study~* Patient with operable biliary carcinoma~* Class ASA IV patients~* Patients presenting clinical and laboratory signs of biliary infection~* Absence of bilirubin decrease after stent insertion~* Patients with extrinsic biliary compression~* Patients already having received or currently receiving radiotherapy or chemotherapy for cholangiocarcinoma or needing to be treated during the first month of the follow-up~* Known metastatic lesions~* Patients having received immediate treatment by insertion of a metal stent~* Patients with porphyria or known hypersensitivity to porphyrins (contraindication to WST11)~* Patient receiving prohibited treatment at the time of inclusion in the study~* Pregnant or breast-feeding women~* Non-menopausal women not using effective contraception~* Majors under protection as per the French Public Health Code~* Persons not registered with or covered by a social security system~* Persons in an exclusion period relative to other biomedical study

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- WST11 (Type: EXPERIMENTAL): Treatment with WST11-mediated VTP

Based on this trial design, predict the completion outcome and termination type (if applicable).